Massachusetts H4950: An Act relative to insulin access

What the bill says

From the introduced text, January 28, 2026:

SECTION 1. Section 17G chapter 32A of the General Laws, as appearing in the 2022 Official Edition, is hereby amended by adding the following paragraph:- The commission shall cap the total amount that an individual is required to pay for insulin at an amount not to exceed $100 per a 30-day supply of insulin, regardless of the amount or type of insulin needed to fill the individual’s prescription. SECTION 2. Chapter 111N of the General Laws is hereby amended by adding the following section:- Section 9. (a) As used in this section, the following words shall, unless the context clearly requires otherwise, have the following meanings:- “Individuals who urgently need insulin”, individuals who have less than a 7-day supply of insulin and are likely to ration insulin without assistance. “Insulin patient assistance program”, assistance in the form of insulin free of charge for a specified duration provided by a manufacturer to an eligible individual, including, but not limited to: (i) directly to an eligible individual’s licensed practitioner for dispensing or (ii) to an eligible individual through a single-use card that can be used at a pharmacy when accompanied by a prescription. (b) Every pharmaceutical or medical device manufacturing company, as defined in section 1, engaged in the production and distribution of insulin with a Medicaid drug rebate agreement pursuant to …

Read the full official text

Sponsors

• Services, Joint Committee on Financial (I) · primary sponsor
• Erika Uyterhoeven (D, 27th Middlesex)
• Kelly Pease (R, 4th Hampden)
• Brian Murray (D, 10th Worcester)
• Patrick Kearney (D, 4th Plymouth)
• Vanna Howard (D, 17th Middlesex)
• Lindsay Sabadosa (D, 1st Hampshire)
• David LeBoeuf (D)

Latest actions

1. July 9, 2026: Reporting date extended to Thursday, December 31, 2026
2. January 28, 2026: Reported favorably by committee and referred to the committee on Health Care Financing
3. January 28, 2026: New draft of H1240
4. January 28, 2026: Reported from the committee on Financial Services

Votes

• Committee Vote - Joint Committee on Financial Services (December 23, 2025): 11 yea, 0 nay, passed

Common questions

What is H4950?

H4950 is a bill in the Massachusetts Legislature (194th General Court): An Act relative to insulin access.

What is the status of H4950?

In committee as of July 9, 2026. Latest action: Reporting date extended to Thursday, December 31, 2026 (July 9, 2026).

Who sponsored H4950?

Services, Joint Committee on Financial (I), with 7 co-sponsors.

Where is the official record for H4950?

On the Massachusetts Legislature website: https://malegislature.gov/Bills/194/H4950